Rob Volansky is a Staff Writer at HEMONC TODAY. He covers a wide range of topics within medicine and healthcare, including rheumatology, patient care, public health, and digital health, with a particular focus on healthcare systems and technology. Rob's insights and expertise have also been featured in Healio.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Destin, United States (Local)
Not enough data
Rob's coverage predominantly focuses on healthcare and pharmaceuticals, particularly in the field of rheumatology and autoimmune diseases. He relies heavily on data citations, indicating a preference for evidence-based information.
Since Rob covers a niche area within the medical field, he is likely to be interested in pitches that provide new research findings or expert insights related to rheumatology, autoimmune diseases, COVID-19 impact on these conditions, vaccines' effect on patients with such illnesses, and developments in relevant medications.
Given his high reliance on data citations, sources with access to cutting-edge research or clinical trial results would have significant appeal. Expert commentary from professionals directly involved in treating these conditions could also capture his interest.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Rob Volansky, Shenaz Bagha
HUNTINGTON BEACH, Calif. — Treatment options are coming into focus for patients with interstitial lung disease in systemic sclerosis , albeit slowly, according to a presenter at the Congress of Clinical Rheumatology West.
By: Shenaz Bagha, Rob Volansky
HUNTINGTON BEACH, Calif. — Osteoporosis prevention and management should begin at perimenopause and continue indefinitely as needed, according to a presenter at the Congress of Clinical Rheumatology West.
By: Rob Volansky, Shenaz Bagha
Nearly three-quarters of individuals from a large-scale prospective study who met American College of Rheumatology criteria for fibromyalgia never
By: Shenaz Bagha, Rob Volansky
Among a cohort of U.S. military veterans with rheumatoid arthritis , those with frailty and older age demonstrated an increased risk for cancer, according to data published in Arthritis Care & Research.
By: Hakon Hakonarson, Rob Volansky, Shenaz Bagha
Pediatric immune-mediated inflammatory diseases are genetically distinct from their adult counterparts and should not be viewed as “younger versions
By: Rob Volansky, Shenaz Bagha
Osteoporosis diagnosis and treatment in gout remain insufficient despite patients with gout demonstrating higher rates of osteoporotic fracture than
By: Shenaz Bagha, Rob Volansky
Escalating allopurinol in patients with gout is safe despite “mild” elevations in serum aminotransferase, according to findings published in Arthritis Care & Research
By: Shenaz Bagha, Rob Volansky
Patients with autoimmune rheumatic disease who received an updated or booster COVID-19 vaccine demonstrated lower odds of COVID-related hospitalization vs. those who received the initial series only, according to data
By: Shenaz Bagha, Rob Volansky
Dietary supplement use is “extremely common” in patients with lupus, with nearly 30% taking at least one supplement-medication combination with a potential interaction, according to data published in Arthritis Care & Research.
By: Shenaz Bagha, Rob Volansky
Data linking estrogen-only therapy for menopausal women to a modest increase in autoimmune disease risk, vs. estrogen-plus-progestogen, reinforce
